• Press Room

    SCAI Women in Innovations can provide unique access to real women living with heart disease, experts on the topic of gender-based disparities in cardiovascular research, female interventionalists recognized as experts in the field, and more. For more information or to arrange an interview, please contact:

    Kathy Boyd David
    SCAI
    717-422-1181
    kbdavid@scai.org 

  • Recent News Releases

    September 02, 2013

    LANCET STUDY AFFIRMS DRUG-ELUTING STENTS ARE SAFE AND EFFECTIVE FOR WOMEN

    A new worldwide study shows women with blocked heart arteries are good candidates for treatment with drug-eluting stents. Presented today in a Clinical Trial Update Hot Line Session at the ESC Congress 2013 (European Society of Cardiology) and simultaneously published in The Lancet, the study provides critical information on the treatment of women, who are historically underrepresented in clinical trials.
    August 08, 2013

    SCAI WIN Initiatives and HDRC Presented at FDA Health of Women Workshop

    Two SCAI Women in Innovations (WIN) initiatives and SCAI’s newest health disparities program were featured at this summer’s Food and Drug Administration (FDA) Health of Women (HoW) workshop, where more than 100 stakeholders from academia, government, and industry discussed strategies for promoting women’s health and understanding sex-specific differences in medical research.
    March 21, 2013

    SCAI WIN OB/GYN Patient Screening Project Launches Second Phase

    The OB/GYN patient screening pilot program launched by SCAI-Women in Innovations (“WIN”) and Abbott Vascular’s Women’s Heart Health Initiative made huge strides in 2012, as impressive early results were presented at medical meetings across the United States and journalists picked up the story.
    November 14, 2012

    WIN Launches TAVI Registry in Europe

    In March 2013, SCAI Women in Innovations (“WIN”) will begin collecting registry data on female patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) with commercially available valves and delivery systems in Europe.
    August 31, 2012

    SCAI Women in Innovations Taps National Cardiovascular Data Registry

    Furthering its mission of launching innovative research and educational activities that drive improved outcomes for women with cardiovascular disease, the SCAI Women in Innovations (“WIN”) initiative is undertaking two projects that will use the National Cardiovascular Data Registry (NCDR) to help uncover new information about why women often experience worse outcomes than men when undergoing similar cardiovascular procedures.